MENU
+Compare
STIM
Stock ticker: NASDAQ
AS OF
Jul 16 closing price
Price
$3.60
Change
-$0.14 (-3.74%)
Capitalization
141.64M

STIM Neuronetics Forecast, Technical & Fundamental Analysis

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders... Show more

STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for STIM with price predictions
Jul 16, 2025

STIM in +9.04% Uptrend, rising for three consecutive days on July 14, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where STIM advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 10, 2025. You may want to consider a long position or call options on STIM as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for STIM just turned positive on June 30, 2025. Looking at past instances where STIM's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for STIM moved out of overbought territory on July 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STIM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

STIM broke above its upper Bollinger Band on July 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for STIM entered a downward trend on July 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STIM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.212) is normal, around the industry mean (24.469). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.944) is also within normal values, averaging (42.883).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

STIM is expected to report earnings to fall 61.33% to -8 cents per share on August 12

Neuronetics STIM Stock Earnings Reports
Q2'25
Est.
$-0.08
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.09
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.06
The last earnings report on May 06 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 1.59M shares outstanding, the current market capitalization sits at 141.64M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive therapies for psychiatric and neurological disorders

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3222 Phoenixville Pike
Phone
+1 610 640-4202
Employees
203
Web
https://www.neurostar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WPFH1.600.04
+2.56%
WPF Holdings, Inc.
PTALF0.51N/A
+0.99%
PetroTal Corp.
PIAC0.06N/A
N/A
Princeton Capital Corporation
UPMKF27.28N/A
N/A
UPM-Kymmene Corp.
YMZBY180.00N/A
N/A
Yamazaki Baking Co. Ltd.

STIM and Stocks

Correlation & Price change

A.I.dvisor tells us that STIM and DIZTF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STIM and DIZTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-3.74%
DIZTF - STIM
31%
Poorly correlated
N/A
BWAY - STIM
28%
Poorly correlated
-0.41%
ALGN - STIM
26%
Poorly correlated
-1.33%
NEO - STIM
26%
Poorly correlated
+0.14%
ACRS - STIM
25%
Poorly correlated
+3.95%
More